Advanced search
Publication Cover
Annals of Medicine Volume 54, 2022 - Issue 1
Submit an article Journal homepage
2,563
Views
2
CrossRef citations to date
0
Altmetric
Gastroenterology & Hepatology

Coeliac disease in the COVID-19 pandemic: does HLA have a protective effect?

N. Grecoa Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy
,
A. Meaccia Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy
,
B. Morab Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy
,
A. Vestric Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Rome, Italy
&
A. Picarellia Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, ItalyCorrespondence[email protected]
Pages 617-621 | Received 02 Dec 2021, Accepted 04 Feb 2022, Published online: 17 Feb 2022

References

  • Guo YR, Cao QD, Hong ZS, et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status. Mil Med Res. 2020;7(1):11.
  • Tyrrell DA, Bynoe ML. Cultivation of viruses from a high proportion of patients with colds. Lancet. 1966;1(7428):76–77.
  • Kumar V. Emerging human coronavirus infections (SARS, MERS, and COVID-19): where they are leading us. Int Rev Immunol. 2021;40(1-2):5–53.
  • Kumar V. Understanding the complexities of SARS-CoV2 infection and its immunology: a road to immune-based therapeutics. Int Immunopharmacol. 2020;88:106980.
  • Chan JF, Yuan S, Kok KH, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person‐to‐person transmission: a study of a family cluster. Lancet. 2020;S0140-6736(20):30154–30159.
  • Guan W, Ni Z, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708–1720.
  • Ye Q, Wang B, Mao J. Cytokine storm in COVID-19 and treatment. J Infect. 2020;80(6):607–613.
  • Onder G, Rezza G, Brusaferro S. Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. JAMA. 2020;323(18):1775–1776.
  • Bhoori S, Rossi RE, Citterio D, et al. COVID-19 in long-term liver transplant patients: preliminary experience from an Italian Transplant Centre in Lombardy. Lancet Gastroenterol Hepatol. 2020;5(6):532–533.
  • Igueroa-Parra G, Aguirre-Garcia GM, Gamboa-Alonso CM, et al. Are my patients with rheumatic diseases at higher risk of COVID-19? Ann Rheum Dis. 2020;79(6):839–840.
  • Catassi GN, Vallorani M, Cerioni F, et al. A negative fallout of COVID-19 lockdown in Italy: life-threatening delay in the diagnosis of celiac disease. Dig Liver Dis. 2020;52(10):1092–1093.
  • Green PHR, Lebwohl B, Greywoode R. Celiac disease. J Allergy Clin Immunol. 2015;135(5):1099–1106.
  • Vader W, Stepniak D, Kooy Y, et al. The HLA-DQ2 gene dose effect in celiac disease is directly related to the magnitude and breadth of gluten-specific T cell responses. Proc Natl Acad Sci U S A. 2003;100(21):12390–12395.
  • Dendrou CA, Petersen J, Rossjohn J, et al. HLA variation and disease. Nat Rev Immunol. 2018;18(5):325–339. ‐
  • Nguyen A, David JK, Maden SK, et al. Human leukocyte antigen susceptibility map for severe acute respiratory syndrome coronavirus 2. J Virol. 2020;94(13):510–520.
  • Lin M, Tseng HK, Trejaut JA, et al. Association of HLA class I with severe acute respiratory syndrome coronavirus infection. BMC Med Genet. 2003;4(1):9.
  • Langton DJ, Bourke SC, Lie BA, et al. The influence of HLA genotype on the severity of COVID-19 infection. HLA. 2021;98(1):14–22.
  • Tavasolian F, Rashidi M, Hatam GR, et al. HLA, immune response, and susceptibility to COVID-19. Front Immunol. 2021;11:601886.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.